Purple Biotech (PPBT) Interest Income - Deposits (2017 - 2026)
Purple Biotech (PPBT) posted quarterly Interest Income - Deposits of $47000.0 for Q1 2026, up 30.56% year-over-year from $36000.0 in Q1 2025, and down 9.62% quarter-over-quarter from $52000.0 in Q4 2025.
Purple Biotech (PPBT) Interest Income - Deposits (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has reported Interest Income - Deposits for 10 consecutive years, with $47000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Income - Deposits rose 30.56% year-over-year to $47000.0; the TTM figure through Mar 2026 stood at $197000.0 (down 14.72% YoY), while the FY2025 annual figure was $186000.0, down 41.87% from the prior year.
- Interest Income - Deposits slipped to $47000.0 in Q1 2026 per PPBT's latest filing, from $52000.0 in the prior quarter.
- Across five years, Interest Income - Deposits topped out at $352000.0 in Q1 2023 and bottomed at $10000.0 in Q2 2022.
- Historically, Interest Income - Deposits has averaged $102000.0 across 5 years, with a median of $77500.0 in 2023.
- Annual changes were most pronounced in 2022 — Interest Income - Deposits plunged 86.67% — and 2023, when it surged 1860.0%.
- Purple Biotech's Interest Income - Deposits stood at $181000.0 in 2022, then plunged by 55.8% to $80000.0 in 2023, then tumbled by 52.5% to $38000.0 in 2024, then jumped by 36.84% to $52000.0 in 2025, then retreated by 9.62% to $47000.0 in 2026.
- Business Quant data shows PPBT's Interest Income - Deposits at $47000.0 in Q1 2026, $52000.0 in Q4 2025, and $49000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Deposits (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Purple Biotech | 130.35 | 130.35 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 38,000.00 |
| Sep 30, 2024 | 75,000.00 |
| Jun 30, 2024 | 82,000.00 |
| Mar 31, 2024 | 125,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Sep 30, 2023 | 127,000.00 |
| Jun 30, 2023 | 196,000.00 |
| Mar 31, 2023 | 352,000.00 |
| Sep 30, 2022 | 181,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 133,000.00 |
| Dec 31, 2021 | 244,000.00 |
| Sep 30, 2021 | 182,000.00 |
| Jun 30, 2021 | 75,000.00 |
| Mar 31, 2021 | 40,000.00 |